CLYM
Climb Bio
CLYM
CLYM
21 hedge funds and large institutions have $46.2M invested in Climb Bio in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
9% less funds holding
Funds holding: 23 → 21 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
21
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
1 | +$37.7K | |
2 | +$16.2K | |
3 | +$4.61K | |
4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$414 |
5 |
Renaissance Technologies
New York
|
+$38 |
Top Sellers
1 | -$37.3K | |
2 | -$14.4K | |
3 | -$4.68K | |
4 |
BlackRock
New York
|
-$1.93K |
5 |
CPIG
Chicago Partners Investment Group
Chicago,
Illinois
|
-$210 |